Indications for monitoring Heart Failure (HF)
By Richard Carreon
Breast Cancer Awareness month has evolved into year-round opportunities for educating consumers about the need for prevention and early detection. But an important issue that is often overlooked during these campaigns is the devastating impact of breast cancer-related lymphedema (BCRL). BCRL affects three to five million people in the U.S. – up to 65 percent of the 250,000 annual breast cancer patients in this country depending on the type of treatment.
Damage to the lymphatic system from cancer treatments can lead to fluid buildup in the limbs and progressive swelling. If untreated, lymphedema can result in pain, infection, reduced mobility and overall impaired function. The daily harm to quality of life cannot be overstated, often preventing a patient from successfully moving on from cancer treatment.
Fortunately, technologies are now available, allowing for earlier detection and proactive management and prevention of chronic lymphedema, a common side-effect following surgery for breast cancer and other cancers.[Read more…]